Skip to main content
Back to Novo Holdings

Novo Holdings's Biopharma Portfolio

Browse 13 Biopharma companies funded by Novo Holdings. See funding amounts, founder contacts, and investment details.

Biopharma Companies
13
Total Funding in Biopharma
$1.5B

Biopharma Portfolio Companies (13)

Export
BiopharmaBiotechnology

cAMPfield Therapeutics is a biotechnology company that specializes on exploration and development activities of therapeutic solutions.

San Diego, United States
May 2026
Series A

Founder Contacts

19,000+ verified contacts

AnalyticsBiopharmaBiotechnologyHealth CareLife ScienceMedical DevicePharmaceutical

CoultreonBiopharma is developing best-in-class therapeutics that target clinically validated pathways in immunology and metabolic illnesses.

Heverlee, Belgium
April 2026
Series A

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyHealth CarePharmaceutical

Spruce Biosciences is a biopharmaceutical company developing therapies for rare diseases that target the endocrine system.

South San Francisco, United States
April 2026
Post-IPO Equity

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyLife ScienceMedical

MapLight Therapeutics is a biopharma company that offers a platform designed to discover and develop therapeutics for brain disorders.

Palo Alto, United States
July 2025
$372.5M
Series D

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyMedicalPharmaceutical

Avalyn Pharma is a biopharma company developing therapies for the treatment of idiopathic pulmonary fibrosis and other respiratory diseases.

Seattle, United States
July 2025
$100.0M
Series D

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyHealth CareHealth DiagnosticsLife ScienceMedicalTherapeutics

Numab is a biotechnology company that offers antibody-based therapeutics for the treatment of severe diseases.

Wadenswil, Switzerland
January 2025
$54.9M
Series C

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyMedicalPharmaceutical

Muna Therapeutics discovers and develops therapies that slow or stop neurodegenerative diseases such as alzheimer’s and parkinson's.

Copenhagen, Denmark
January 2026
$1.0M
Grant

Founder Contacts

19,000+ verified contacts

BiopharmaHealth CareMedicalTherapeutics

Crystalys Therapeutics is a clinical-stage biopharmaceutical company transforming the treatment of gout.

San Diego, United States
September 2025
$205.0M
Series A

Founder Contacts

19,000+ verified contacts

BiopharmaTherapeutics

BBOT is a clinical-stage biopharmaceutical company advancing a pipeline of novel therapeutics targeting RAS and PI3Kα malignancies.

Palo Alto, United States
August 2025
$261.0M
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyPharmaceutical

Augustine Therapeutics is discovering and developing innovative medicines for the treatment of neuromuscular and neurodegeneratives diseases

Leuven, Belgium
March 2025
$83.9M
Series A

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyMedical

AnaCardio is a clinical stage biopharmaceutical company developing novel drugs to treat heart failure.

Solna, Sweden
January 2025
$18.4M
Series A

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyHealth Care

Harmony Biosciences is a pharmaceutical company that develops and commercializes novel therapies for rare neurological disorders.

Plymouth Meeting, United States
October 2024
$248.0M
Post Ipo Secondary

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyHealth CareLife SciencePharmaceutical

Arcellx develops engineered cell-based immunotherapies for the treatment of cancer and other serious diseases.

Redwood City, United States
November 2023
$200.0M
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

Explore Novo Holdings's Full Portfolio

View all companies funded by Novo Holdings across every industry and funding stage.

View Full Novo Holdings Portfolio